Latest Breaking News On - Jeffrey moses - Page 1 : vimarsana.com

Drug-coated balloon shows superiority in coronary in-stent restenosis treatment

In the largest randomized clinical trial and first of its kind to date in the United States, a team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) assessed the efficacy and safety of using a drug-coated balloon in patients undergoing coronary angioplasty.

FDA Approves BIDMC's Coronary Drug-Coated Balloons After Trial

BIDMC-led trial leads to FDA approval of coronary drug-coated balloons

In the largest randomized clinical trial and first of its kind to date in the United States, a team led by investigators at Beth Israel Deaconess Medical Center

BIDMC-led trial leads to FDA approval of coronary drug-coated balloons

In the largest randomized clinical trial and first of its kind to date in the United States, a team led by investigators at Beth Israel Deaconess Medical Center

December 7 disasters

Seychelles Pension Fund lends a hand   To help ease the financial pressures of employers who have been affected by the December 7 explosion, the Seychelles Pension Fund (SPF) has .

PCI's Role for Patients With HFrEF and Extensive CAD: Experts Debate

It’s clear the REVIVED-BCIS2 trial hasn’t put an end to PCI in this setting. But it should be used cautiously, Eric Velazquez says.

Conversations in Cardiology: ISCHEMIA's Lasting Fallout

Some interventional cardiologists are choosing to defer PCI, but is this justified? And will a drop in case volume have ill effects?

US Claims Data Point to Better Survival With Impella vs IABP in High-Risk PCI

This latest propensity-adjusted analysis also linked Impella to less MI and cardiogenic shock. RCT results still lie years ahead.

CCTA in Patients With Prior CABG Cuts Complications of Invasive Angio: BYPASS-CTCA

One researcher calls this practice a “no-brainer” but acknowledges that not everyone will have access to CT.

Conversations in Cardiology: Do You Use Antibiotics?